| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |